Poisoning and epidemiology: 'Toxicoepidemiology'

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 3-4, 1998, Pages 195-203

  Buckley, Nicholas A ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Clinical research; Cochrane Collaboration; Epidemiology; Evidence based; Poisoning

Indexed keywords

CLINICAL RESEARCH; CLINICAL STUDY; EVIDENCE BASED MEDICINE; HUMAN; INFORMATION PROCESSING; INTOXICATION; REVIEW; SUICIDE; TOXICOLOGY;

EID: 0031967248     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.t01-5-.x     Document Type: Review

References (93)

1. Diekstra RFW. Suicide and attempted suicide: An international perspective. Acta Psychiatr. Scand. 1989; 80 (Suppl. 354): 1-24.
2. Buckley NA, Dawson AH, Whyte IM, McManus P, Ferguson N. Six years of self-poisoning in Newcastle: 1987-1992. Med. J. Aust. 1995; 162: 190-3.
3. Bialis MC, Reid PG, Beck P et al. Changing patterns of poisoning in a UK health district. Q. J. Med. 1996; 89: 893-901.
4. Obafunwa JO, Busuttil A. Deaths from substance overdose in the Lothian and Borders Region of Scotland (1983-1991). Hum. Exp. Toxicol. 1994; 13: 401-6.
5. Office of Population Censuses and Surveys. Deaths from poisoning by solid or liquid substances: Accidental, suicidal and undetermined whether accidentally taken or purposely inflicted, 1983-1992. Her Majesty's Stationery Office, London. 1994; Series DH4 no. 13.
6. Davis AT, Kosky RJ. Attempted suicide in Adelaide and Perth: Changing rates for males and females, 1971-1987. Med. J. Aust. 1991; 154: 666-85.
7. Wynne H, Bateman DN, Hassanyeh F, Rawlins MD, Woodhouse KW. Age and self-poisoning: The epidemiology in Newcastle upon Tyne in the 1980s. Hum. Toxicol. 1987; 6: 511-15.
8. Meredith TJ, Vale JA, Goulding R. The epidemiology of acute acetaminophen poisoning in England and Wales. Arch. Intern. Med. 1981; 141: 397-400.
9. Fuller GN, Rea AJ, Payne JF, Lant AF. Parasuicide in central London 1984-1988. J. R. Soc. Med. 1989; 82: 653-6.
10. Hawton K, Fagg J. Trends in deliberate self poisoning and self injury in Oxford, 1976-90. BMJ 1992; 304: 1409-11.
11. Pond SM. Prescription for poisoning. Med. J. Aust. 1995; 162: 174-5.
12. Ellenhorn MJ. Medical Toxicology: Diagnosis and Treatment of Human Poisoning, 2nd edn. Williams & Wilkens, Baltimore. 1997.
13. Dorman T. Toxicity of tricyclic antidepressants: Are there important differences? J. Int. Med. Res. 1985; 13: 77-83.
14. Kalow W. Pharmacogenetics: Its biological roots and the medical challenge. Clin. Pharmacol. Ther. 1993; 54: 235-41.
15. Gonzalez FJ, Gelboin HV. Role of human cytochrome P-450s in risk assessment and susceptibility to environmentally based disease. J. Toxicol. Environ. Health 1993; 40: 289-308.
16. Patten CJ, Thomas PE, Guy RL et al. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem. Res. Toxicol. 1993; 6: 511-18.
17. Marley RJ, Elmer GI, Goldberg SR. The use of pharmacogenetic techniques in drug abuse research. Pharmacol. Ther. 1992; 53: 217-37.
18. Buckley NA, Smith AJ. Evidence based medicine in toxicology: Where is the evidence? Lancet 1996; 347: 1167-9.
19. Blanc PD, Jones MR, Olson KR. Surveillance of poisoning and drug overdose through hospital discharge coding, poison control center reporting, and the Drug Abuse Warning Network. Am. J. Emerg. Med. 1993; 11: 14-19.
20. Blanc PD, Kearney TE, Olson KR. Underreporting of fatal cases to a regional poison control center. West. J. Med. 1995; 162: 505-9.
21. Harchelroad F, Clark RF, Dean B, Krenzelok EP. Treated vs. reported toxic exposures: Discrepancies between a poison control center and a member hospital. Vet. Hum. Toxicol. 1990; 32: 156-9.
22. Veltri JC, McElwee NE, Schumacher MC. Interpretation and uses of data collected in poison control centres in the United States. Med. Toxicol. 1987; 2: 389-97.
23. Woolf A, Liebelt Z, Lovejoy FH. Pediatric poisoning hazards. Pediatrics 1993; 91: 1017.
24. Tenenbein M. Benefits of parenteral deferoxamine for acute iron poisoning. J. Toxicol. Clin. Toxicol. 1996; 34: 485-9.
25. Oxman AD (ed.). Section VI: Preparing and maintaining systematic reviews. In: Cochrane Collaboration Handbook. Cochrane Collaboration, Oxford. 1994.
26. Raphael JC, Elkharrat D, Jars-Guincertie MC et al. Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 1989; ii: 414-19.
27. Thom SR, Taber RL, Mendiguren II, Clark JM, Hardy KR, Fisher AB. Delayed neuropsychologic sequelae after carbon monoxide poisoning: Prevention by treatment with hyperbaric oxygen. Ann. Emerg. Med. 1995; 25: 474-80.
28. Olson KR, Seger D. Hyperbaric oxygen for carbon monoxide poisoning: Does it really work? Ann. Emerg. Med. 1995; 25: 535-7.
29. Tibbles PM, Perrotta PL. Treatment of carbon monoxide poisoning: A critical review of human outcome studies comparing normobaric oxygen with hyperbaric oxygen. Ann. Emerg. Med. 1994; 24: 269-76.
30. Kulig K, Bar-Or D, Cantrill SV, Rosen P, Rumack BH. Management of acutely poisoned patients without gastric emptying. Ann. Emerg. Med. 1985; 14: 562-7.
31. Pond SM, Lewis-Driver DJ, Williams GM, Green AC, Stevenson NW. Gastric emptying in acute overdose: A prospective randomised controlled trial. Med. J. Aust. 1995; 163: 345-9.
32. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996; 312: 1215-18.
33. Ritz R, Zuber M, Elsasser S, Scollo-Lavizzari G. Use of flumazenil in intoxicated patients with coma. A double-blind placebo-controlled study in ICU. Intens. Care Med. 1990; 16: 242-7.
34. Weinbroum A, Rudick V, Sorkine P et al. Use of flumazenil in the treatment of drug overdose: A double-blind and open clinical study in 110 patients. Crit. Care Med. 1996; 24: 199-206.
35. Marchant B, Wray R, Leach A, Nama M. Flumazenil causing convulsions and ventricular tachycardia. BMJ 1989; 299: 860.
36. Short TG, Maling TG, Galletly DC. Ventricular arrhythmias precipitated by flumazenil. BMJ 1988; 296: 1070-1.
37. Whyte IM, Buckley NA. Progress in clinical toxicology: from case reports to toxicoepidemiology. Med. J. Aust. 1995; 163: 340-1 (Editorial).
38. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-12.
39. Charlton BG, Taylor PRA, Proctor SJ. The PACE (population adjusted clinical epidemiology) strategy: A new approach to multi centre clinical research. Q. J. Med. 1997; 90: 147-51.
40. ICD-10. International Statistical Classification of Diseases and Related Health Problems, 10th revision. Geneva: World Health Organization, 1992.
41. Crome P. The toxicity of drugs used for suicide. Acta Psychiatr. Scand. 1993; 371 (Suppl.): 33-7.
42. Johns MW. Self poisoning with barbiturates in England and Wales during 1959-74. BMJ 1977; i: 1128-30.
43. King LA, Moffat AC. A possible index of fatal drug toxicity in humans. Med. Sci. Law 1983; 23: 193-8.
44. Cassidy S, Henry J. Fatal toxicity of antidepressant drugs in overdose. BMJ 1987; 295: 1021-4.
45. Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ 1995; 310: 221-4.
46. Henry JA, Antao CA. Suicide and fatal antidepressant poisoning. Eur. J. Med. 1992; 1: 343-8.
47. Serfaty M, Masterton G. Fatal poisonings attributed to benzodiazepines in Britain during the 1980s. Br. J. Psychiatry 1993; 163: 386-93.
48. Buckley NA, McManus P. The fatal toxicity of drugs used in the treatment of psychotic illness. Proc. Australas. Soc. Clin. Exp. Pharmacol. Toxicol. 1996; 3: 168 (Abstract).
49. Kapur S, Mieczkowski T, Mann J. Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA 1992; 268: 3441-5.
50. Kelleher MJ, Daly M, Kelleher MJA. The influence of antidepressants in overdose on the increased suicide rate in Ireland between 1971 and 1988. Br. J. Psychiatry 1992; 161: 625-8.
51. Pinder RM. The benefits and risks of antidepressant drugs. Hum. Psychopharmacol. 1988; 3: 73-86.
52. Dwyer PS, Jones IF. Fatal self-poisoning in the UK and the paracetamol/dextropropoxyphene combination. Hum. Toxicol. 1984; 3: S145-74.
53. Hardwick C, Holt L, James R, Smith A. Trends in self poisoning with drugs in Newcastle, NSW 1980-1982. Med. J. Aust. 1986; 144: 453-4.
54. Myers J, Smith A, Elliot R, MacAskill P. Self poisoning with drugs. A 31/2 year study in Newcastle, NSW. Med. J. Aust. 1981; 2: 402-5.
55. Jacobsen D, Frederichson PS, Knutsen KM et al. A prospective study of 1212 cases of acute poisoning: General epidemiology. Hum. Toxicol. 1984; 3: 93-106.
56. Meredith TJ. Epidemiology of poisoning. Pharmacol Ther. 1993; 59: 251-6.
57. Chan TY, Critchley JA, Chan MT, Yu CM. Drug overdosage and other poisoning in Hong Kong: The Prince of Wales Hospital (Shatin) experience. Hum. Exp. Toxicol. 1994; 13: 512-15.
58. Department of Health and Family Services. Australian Statistics on Medicines 1995. Australian Government Printing Office, Canberra. 1997.
59. Buckley NA, Dawson AH, Whyte IM, McManus P, Ferguson N. Correlations between prescriptions and drugs taken in self-poisoning: Implications for prescribers and drug regulation. Med. J. Aust. 1995; 162: 194-7.
60. Spector R, Rogers H, Roy D. Drug treatment in affective disorders. In: Psychiatry: Common drug treatments. Methuen, Melbourne. 1984.
61. Buckley NA, Whyte IM, Dawson AH, Hazell P, Meza A, Britt H. An analysis of age and gender influences on the risk for suicide and psychotropic drug self-poisoning. Acta Psychiatr. Scand. 1996; 93: 168-71.
62. Buckley NA, Dawson AH, Whyte IM, Henry DA. Greater toxicity of dothiepin in overdose than of other tricyclic antidepressants. Lancet 1994; 343. 159-62.
63. Wedin GP, Oderda G, Klein-Schwartz W, Gorman R. Relative toxicity of cyclic antidepressants. Ann. Emerg. Med. 1986; 14: 797-804.
64. Buckley NA, Whyte IM, Dawson AH, O'Connell D. The relative toxicity of benzodiazepines in overdose. BMJ 1995; 310: 219-21.
65. Buckley NA, Whyte IM, Dawson AH. Thioridazine has greater cardiotoxicity in overdose than other neuroleptics. J. Toxicol. Clin. Toxicol. 1995; 33: 199-204.
66. Buckley NA, Dawson AH, Whyte IM, Cruickshank DA. Pheniramine: A much abused drug. Med. J. Aust. 1994; 160: 188-92.
67. Reith DA, Dawson AH, Whyte IM, Buckley NA, Sayer G. The relative toxicity of beta blockers in overdose. J. Toxicol. Clin. Toxicol. 1996; 34: 273-8.
68. Reith DM, Buckley NA, Whyte IM, Carter G. Clinical features of self-poisoning with monoamine oxidase inhibitors and/or serotonin reuptake inhibitors. Proc. Australas. Soc. Clin. Exp. Pharmacol. Toxicol. 1996; 3: 29 (Abstract).
69. Whyte IM, Buckley NA. Relative toxicity and resource utilisation in antidepressant self poisoning: Tricyclics vs. specific serotonin reuptake inhibitors. Proc. Australas. Soc. Clin. Exp. Pharmacol. Toxicol. 1995; 2: 103 (Abstract).
70. Sacket DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: A basic science for clinical medicine, 2nd ed. Little, Brown and Company, Boston. 1991.
71. Buckley NA. Clinical usefulness of toxidromes. In: Chan B (ed.). Proceedings of the 2nd Australasian Clinical Toxicology Conference, 1997. Sydney: Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists. 1997.
72. Buckley NA, O'Connell D, Whyte IM, Dawson AH. Inter-rater agreement in the measurement of QRS duration in tricyclic antidepressant overdose: Implications for monitoring and research. Ann. Emerg. Med. 1996; 28: 515-19.
73. Liebelt EL, Francis PD, Woolf AD. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann. Emerg. Med. 1995; 26: 195-201.
74. Chevalier S, Buckley NA, O'Connell D, Leitch JW. ECG predictors of arrhythmias after tricyclic and thioridazine overdose. Proceedings of the Cardiac Society of Australia and New Zealand Annual conference. Aust. N.Z. J. Med. 1995; 25: 652.
75. Boehnert MT, Lovejoy FH. Value of the QRS duration vs. the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N. Engl. J. Med. 1985; 313: 474-9.
76. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: Analysis of the national multicenter study (1976-1985). N. Engl. J. Med. 1988; 319: 1557-62.
77. Prescott LF, Illingworth RN, Critchley JAJH, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: The treatment of choice for paracetamol poisoning. BMJ 1979; 2: 1097-100.
78. Harrison PM, Keays R, Bray GP, Alexander GJM, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990; 335: 1572-3.
79. Dawson AH, Buckley NA, Whyte IM, Cullen P, O'Connell D. Activated charcoal and intravenous N-acetylcysteine: The treatment of choice for early paracetamol poisoning? Proc. Australas. Soc. Clin. Exp. Pharmacol. Toxicol. 1994; 1: 30 (Abstract).
80. Vale JA, Proudfoot AT. Paracetamol (acetaminophen) poisoning. Lancet 1995; 346: 547-52.
81. Wiseman HM, Guest K, Murray VSG, Volans GN. Accidental poisoning in childhood: A multicentre survey. 2. The role of packaging in accidents involving medications. Hum. Toxicol. 1987; 6: 303-14.
82. Buckley NA, Newby DA, Dawson AH, Whyte IM. The effect of repackaging of carbamazepine on adult self-poisoning. Pharmacoepidemiol. Drug Safety 1995; 4: 351-4.
83. Chan TYK. Safety packaging of acetaminophen combination preparations and severity of adult poisoning. J. Toxicol. Clin. Toxicol. 1996; 34: 747-9.
84. Checkoway H, Pearce N, Crawford-Brown DJ. Research methods in occupational epidemiology. Oxford University Press, Oxford. 1989.
85. Rahde AF. The epidemiology of poisoning: A monitoring program for developing countries. Vet. Hum. Toxicol. 1992; 34: 261-3.
86. Litovitz TL, Felberg L, White S, Klein-Schwartz W. 1995 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am. J. Emerg. Med. 1996; 14: 487-537.
87. Henderson A, Wright M, Pond SM. Experience with 732 acute overdose patients admitted to an intensive care unit over six years. Med. J. Aust. 1993; 158: 28-30.
88. Strom J, Thisted B, Krantz T, Bredgaard Sorensen M. Self-poisoning treated in an ICU: Drug pattern, acute mortality and short-term survival. Acta Anaesthesiol. Scand. 1986; 30: 148-53.
89. de Silva HJ, Wijewickrema R, Senanayake N. Does pralidoxime affect outcome of management in acute organophosphorus poisoning? Lancet 1992; 339: 1136-8.
90. Michel K, Waeber V, Valach L, Arestegui G, Spuhler T. A comparison of the drugs taken in fatal and non fatal self poisoning. Acta Psychiatr. Scand. 1994; 90: 184-9.
91. Owens D, House A. General hospital services for deliberate self-harm. Haphazard clinical provision, little research, no central strategy. J. R. Coll. Physicians Lond. 1994; 28: 370-1.
92. Meredith T, Haines J. International data collection and evidence-based clinical toxicology. J. Toxicol. Clin. Toxicol. 1996; 34: 647-9.
93. International Program on Chemical Safety (IPCS), INTOX Working Group Editorial Board. Instructions for the preparation of poison information monographs (PIMs). Geneva: IPCS/IDRC. 1996; IPCS/IDRC/90.46.